Cargando…

Extracorporeal shock wave therapy inhibits osteoclast differentiation by targeting NF-κB signaling pathway

BACKGROUND: Extracorporeal shock wave therapy (ESWT) has been reported to promote osteoblast differentiation. However, the role of ESWT on osteoclast differentiation is still elusive. METHODS: This study analyzed the differentiation of osteoclasts in the shock wave group and the control group in vit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Bei, Luo, Yeqiang, Zhang, Zhongxiu, Lin, Shanghui, Wang, Renkai, Li, Baofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612311/ https://www.ncbi.nlm.nih.gov/pubmed/37891600 http://dx.doi.org/10.1186/s13018-023-04166-w

Ejemplares similares

Extracorporeal Shock Wave Therapy Promotes Osteogenic Differentiation in a Rabbit Osteoporosis Model
por: Li, Baofeng, et al.
Publicado: (2021)

The clinical outcomes of surgical treatment for chronic ankle instability by anatomical reconstruction of the anterior talofibular ligament with autologous half-bundle peroneal longus tendon: A retrospective study
por: Luo, Yeqiang, et al.
Publicado: (2022)

Inhibition of Osteoclast Differentiation by Carotenoid Derivatives through Inhibition of the NF-κB Pathway
por: Odes-Barth, Shlomit, et al.
Publicado: (2020)

Nur77 Prevents Osteoporosis by Inhibiting the NF‐κB Signalling Pathway and Osteoclast Differentiation
por: Tian, Huanlian, et al.
Publicado: (2022)

Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
por: Wei, Rongfang, et al.
Publicado: (2023)

Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2019)

NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-κB and Reactive Oxygen Species Pathways
por: Kim, Jung Ha, et al.
Publicado: (2015)

Methanol Extract of Croton Pycnanthus Benth. Inhibits Osteoclast Differentiation by Suppressing the MAPK and NF-κB Signaling Pathways
por: Lee, Jiyeon, et al.
Publicado: (2014)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
por: Zhou, Lin, et al.
Publicado: (2015)

Diphlorethohydroxycarmalol from Ishige okamurae Suppresses Osteoclast Differentiation by Downregulating the NF-κB Signaling Pathway
por: Ihn, Hye Jung, et al.
Publicado: (2017)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
por: Wu, Lili, et al.
Publicado: (2019)

Punicalin Attenuates Breast Cancer-Associated Osteolysis by Inhibiting the NF-κB Signaling Pathway of Osteoclasts
por: Li, Tao, et al.
Publicado: (2021)

PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-κB Signaling Pathway
por: Duan, Yang, et al.
Publicado: (2019)

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2000)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

Extracorporeal shock wave lithotripsy today
por: Tailly, Geert G
Publicado: (2013)

Extracorporeal shock wave therapy: an update
por: Auersperg, Vinzenz, et al.
Publicado: (2020)

Recombinant Human Endostatin Suppresses Mouse Osteoclast Formation by Inhibiting the NF-κB and MAPKs Signaling Pathways
por: Chen, Nong, et al.
Publicado: (2016)

Extracorporeal Shock Wave Lithotripsy for Gallstones: The Shock of the Eighties
por: Darzi, A., et al.
Publicado: (1990)

Triterpenoid Saponin W3 from Anemone flaccida Suppresses Osteoclast Differentiation through Inhibiting Activation of MAPKs and NF-κB Pathways
por: Kong, Xiangying, et al.
Publicado: (2015)

Paroxetine Attenuates Chondrocyte Pyroptosis and Inhibits Osteoclast Formation by Inhibiting NF-κB Pathway Activation to Delay Osteoarthritis Progression
por: Zheng, Xiaohang, et al.
Publicado: (2023)

Protocatechualdehyde Inhibits the Osteoclast Differentiation of RAW264.7 and BMM Cells by Regulating NF-κB and MAPK Activity
por: Qu, Yunyun, et al.
Publicado: (2021)

Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo
por: Ru, Jiang-Ying, et al.
Publicado: (2016)

Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways
por: Tzeng, Huey-En, et al.
Publicado: (2018)

Vericiguat Modulates Osteoclast Differentiation and Bone Resorption via a Balance between VASP and NF-κB Pathways
por: Sun, Kaiqiang, et al.
Publicado: (2022)

Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway
por: Zhu, Shijun, et al.
Publicado: (2016)

Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
por: Park, Gyeong Do, et al.
Publicado: (2021)

Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway
por: Ouyang, Xiao, et al.
Publicado: (2022)

Extracorporeal shock wave therapy in musculoskeletal disorders
por: Császár, Nikolaus BM, et al.
Publicado: (2013)

Extracorporeal shock wave lithotripsy: What is new?
por: Bach, Christian, et al.
Publicado: (2012)

Extracorporeal Shock Wave Therapy in Dupuytren’s Disease
por: Aykut, Serkan, et al.
Publicado: (2018)

Extracorporeal Shock Wave Therapy for Achilles Tendinopathy
por: Stania, Magdalena, et al.
Publicado: (2019)

Extracorporeal Shock Wave Therapy for Hypertrophic Scars
por: Chuangsuwanich, Apirag, et al.
Publicado: (2022)

Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis
por: Lee, Won-Seok, et al.
Publicado: (2018)

Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity
por: Deng, Wei, et al.
Publicado: (2022)

Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway
por: Chawalitpong, Supatta, et al.
Publicado: (2018)

Erratum to: Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells
por: Kim, Jeong-Mi, et al.
Publicado: (2017)

Boeravinone B, a natural rotenoid, inhibits osteoclast differentiation through modulating NF-κB, MAPK and PI3K/Akt signaling pathways
por: Piao, Xianyu, et al.
Publicado: (2023)

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway
por: Li, Yajun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_28m58dnddvot27k1bgss14ug9r